Sadoff, Jerald

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 2,397

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

Sadoff, J., Le Gars, M., Shukarev, G., Heerwegh, D., Truyers, C., de Groot, A. M., Stoop, J., Tete, S., Van Damme, W., Leroux-Roels, I., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,208

Use of Azithromycin for the Treatment of Campylobacter Enteritis in Travelers to Thailand, an Area Where Ciprofloxacin Resistance Is Prevalent

Kuschner, R. A., Trofa, A. F., Thomas, R. J., Hoge, C. W., Pitarangsi, C., Amato, S., Olafson, R. P., Echeverria, P., Sadoff, J. C., & Taylor, D. N. (1995) · Clinical Infectious Diseases

Salmonella and Campylobacter epidemiologyTravel-related health issues

Cited by 242

Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination

Barouch, D. H., Stephenson, K. E., Sadoff, J., Yu, J., Chang, A., Gebre, M., McMahan, K., Liu, J., Chandrashekar, A., Patel, S., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations

Cited by 237

Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination

Suscovich, T. J., Fallon, J. K., Das, J., Demas, A. R., Crain, J., Linde, C. H., Michell, A., Natarajan, H., Arevalo, C., Broge, T., et al. (2020) · Science Translational Medicine

Malaria Research and ControlMonoclonal and Polyclonal Antibodies Research

Cited by 142